22 batches of Chinese herbal medicines

Only foreign pharmaceutical companies, Chinese medicine industry did not how to stop this year.

The reporter found that there have been two "good news" and one "bad news" coming to this section in recent days: it is favorable for the central government to allocate 1.49 billion yuan to promote the development of Chinese medicine and the newly released health service industry guidance document clearly emphasizes the development of The importance of medicine; "black swan" because of the Food and Drug Administration found that some of the Chinese Herbal Pieces exist dyeing problems. Guangri

Good: The central government allocated 14.9 billion yuan

The forefront of the State Council’s first directive document has just come out. The central “money bag” has been followed up and implemented. According to the Ministry of Finance website, the central government allocated 14.9 billion yuan to promote the development of the Chinese medicine industry.

“This 1.49 billion yuan public health subsidies for the Chinese medicine sector in 2013 will be earmarked to support local governments in promoting the appropriate technical service capabilities of Chinese medicine at the grass-roots level, enhancing the preventive health care and rehabilitation and clinical service capabilities of Chinese medicine, and building the characteristics of traditional Chinese medicine in rural medical institutions. Advantage specialties, and county-level TCM service capacity building work, etc.” The Ministry of Finance specified this point.

Bad: Dyeing Chinese Herbal Pieces will be investigated

For the entire Chinese medicine industry, this year has ushered in the “rectification year” of the quality of Chinese herbal medicines, and even severely has not allowed the opening of new markets for Chinese herbal medicines. And some hardships will affect the trust and favor of consumers and investors in the industry as a whole.

According to the website of the State Food and Drug Administration, a few days ago, the State Food and Drug Administration organized and conducted a special sampling inspection for illegal dyeing of Chinese herbal medicines. In accordance with the special action plan for the "two-for-two constructions" of drugs, the General Administration of Administration organized sampling of some Chinese herbal medicines produced, operated or used by relevant units in four provinces of Anhui, Gansu, Guangdong and Sichuan. A total of 397 batches of samples were sampled for the special sampling inspection. The inspection confirmed 22 batches of dyeing problems, involving 3 varieties of safflower, corydalis, and saffron. The General Administration of China has instructed the Chinese Herbal Pieces and the related units that have verified the existence of staining problems to investigate and punish them according to law.